封面
市場調查報告書
商品編碼
2054640

心肺體外迴圈設備市場:依產品類型、最終用戶和地區分類

Cardiopulmonary Bypass Equipment Market, By Product Type (Single Roller Pump and Double Roller Pump), By End User (Hospitals, Ambulatory Surgical Centres, Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East and Africa)

出版日期: | 出版商: Coherent Market Insights | 英文 157 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年,心肺體外迴圈裝置市場規模將達到 2.172 億美元,到 2033 年將達到 2.672 億美元。預計從 2026 年到 2033 年,該市場將以 3.0% 的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 2.172億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 3.00% 2033年市場規模預測: 2.672億美元

心肺體外迴圈裝置(CPR)是醫療設備,用於在心血管手術期間為體外供氧並循環血液。近年來,由於心血管疾病病例的增加以及對微創手術需求的成長,全球心肺體外迴圈市場持續成長。 CPR可在諸如開胸手術等手術過程中暫時取代心臟和肺的功能。這使得心肺體外迴圈醫生能夠在患者心臟停止跳動的情況下進行手術,同時患者的血液被泵出、氧合併返回體內循環。 CPR心肺體外迴圈的技術進步提高了安全性、效率和精確度,使複雜的手術成為可能,並推動了市場成長。

提高安全性、效率和精確度的技術使複雜的手術成為可能,推動了市場成長。

市場動態

全球心肺體外迴圈)設備市場的成長受到多種因素的驅動,例如不健康的生活方式以及人口老化導致的全球心血管疾病盛行率上升。世界衛生組織的數據顯示,心血管疾病(CVD)是全球首要死因,每年約有1,790萬人死於心血管疾病。除了對微創手術日益成長的需求外,旨在降低手術風險、減輕患者身體負擔和縮短恢復時間的產品創新也可能推動心肺體外迴圈系統的應用。然而,體外循環設備和手術的高昂成本可能會阻礙市場成長。另一方面,新興經濟體醫療旅遊的蓬勃發展以及醫療基礎設施和服務水準的提升,可能帶來新的成長機會。

本次調查的主要特點

  • 本研究確定了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數對全球心肺體外迴圈設備市場的主要參與者進行了分析:公司概況、產品系列、主要亮點、財務表現和策略。
  • 透過利用本報告中的見解,企業行銷負責人和經營團隊將能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
  • 這份《全球心肺體外迴圈裝置市場報告》旨在為產業內的各類相關人員提供參考,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用分析全球心肺體外迴圈裝置市場中使用的各種策略矩陣,更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 監管趨勢
  • 收購與合作趨勢
  • 資金籌措及投資
  • PEST分析
  • 波特的分析

第4章 全球心肺體外迴圈裝置市場:依產品類型分類,2021-2033年

  • 概述
  • 單輥泵
  • 雙滾輪泵

第5章 全球心肺體外迴圈裝置市場:依最終用戶分類,2021-2033年

  • 概述
  • 醫院
  • 門診手術中心
  • 其他

第6章 全球心肺體外迴圈裝置市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第7章 競爭情勢

  • 公司簡介
    • Medtronic
    • LivaNova
    • Terumo Cardiovascular Systems Corporation
    • Maquet Holding BV & Co. KG
    • Braun Melsungen AG
    • Medica spa
    • Eurosets
    • Fresenius Medical Care AG & Co. KGaA
    • Lepu Medical Technology
    • Elite Life Care
    • OriGen Biomedical
    • Tianjin Medical
    • Soma Technology, Inc.
    • Braile Biomedica
    • CardioGenesis Corporation
    • Century Medical, Inc.
    • Nonin Medical, Inc.
    • Xijian Medical

第8章 分析師建議

  • 機會分析
  • 分析師意見
  • Coherent Opportunity Map

第9章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI2026

Cardiopulmonary Bypass Equipment Market is estimated to be valued at USD 217.2 Mn in 2026 and is expected to reach USD 267.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 3.0% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 217.2 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 3.00% 2033 Value Projection: USD 267.2 Mn

Cardiopulmonary bypass equipment are devices that are used to oxygenate and circulate blood outside the body during cardiac surgery. Global cardiopulmonary bypass equipment market has been witnessing growth over the past few years due to rising cases of cardiovascular diseases and rising demand for minimally invasive surgical procedures. Cardiopulmonary bypass allows temporary takeover of heart and lung functions during procedures such as open-heart surgery. It enables surgeons to work on a still heart while the patient's blood is pumped, oxygenated, and returned to circulation. Advancements in cardiopulmonary

y bypass systems with improved technology for safety, efficiency, and precision have been facilitating complex surgeries and driving the market growth.

Market Dynamics

Global cardiopulmonary bypass equipment market growth is driven by factors like rising prevalence of cardiovascular diseases globally due to unhealthy lifestyle habits and growing geriatric population. According to the data published by WHO, cardiovascular diseases or CVDs are a major cause of mortality worldwide, with an estimated 17.9 million people die due to CVDs each year. Increasing demand for minimally invasive procedures coupled with product innovations to reduce surgical risk, trauma, and recovery time can boost adoption of cardiopulmonary bypass systems. However, high costs associated with bypass equipment and surgeries can hamper the market growth. Meanwhile, emerging economies along with growing medical tourism and improving healthcare infrastructure and services can offer market growth opportunities.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cardiopulmonary bypass equipment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Medtronic, LivaNova (formerly Sorin Group), Terumo Cardiovascular Systems Corporation, Maquet Holding BV & Co. KG, Braun Melsungen AG, Medica s.p.a., Eurosets, Fresenius Medical Care AG & Co. KGaA, Lepu Medical Technology, Elite Life Care, OriGen Biomedical, Tianjin Medical, Soma Technology, Inc., Braile Biomedica, CardioGenesis Corporation, Century Medical, Inc., Nonin Medical, Inc., Xijian Medical
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global cardiopulmonary bypass equipment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiopulmonary bypass equipment market

Market Segmentation

  • By Product Type (Revenue, USD Mn, 2021 - 2033)
  • Single Roller Pump
  • Double Roller Pump
  • By End User (Revenue, USD Mn, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgical Centres
  • Others
  • By Region (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Company Profiles
  • Medtronic
  • LivaNova (formerly Sorin Group)
  • Terumo Cardiovascular Systems Corporation
  • Maquet Holding BV & Co. KG
  • Braun Melsungen AG
  • Medica s.p.a.
  • Eurosets
  • Fresenius Medical Care AG & Co. KGaA
  • Lepu Medical Technology
  • Elite Life Care
  • OriGen Biomedical
  • Tianjin Medical
  • Soma Technology, Inc.
  • Braile Biomedica
  • CardioGenesis Corporation
  • Century Medical, Inc.
  • Nonin Medical, Inc.
  • Xijian Medical

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Cardiopulmonary Bypass Equipment Market, By Product Type, 2021 - 2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Single Roller Pump
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Double Roller Pump
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Cardiopulmonary Bypass Equipment Market, By End User, 2021 - 2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Ambulatory Surgical Centres
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Cardiopulmonary Bypass Equipment Market, By Region, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Mn)
      • North Africa
      • Central Africa
      • South Africa

7. Competitive Landscape

  • Company Profiles
    • Medtronic
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • LivaNova
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Terumo Cardiovascular Systems Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Maquet Holding BV & Co. KG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Braun Melsungen AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Medica s.p.a.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Eurosets
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Fresenius Medical Care AG & Co. KGaA
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Lepu Medical Technology
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Elite Life Care
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • OriGen Biomedical
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Tianjin Medical
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Soma Technology, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Braile Biomedica
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • CardioGenesis Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Century Medical, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Nonin Medical, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Xijian Medical
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies

8. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

9. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact